Abstract
Obstructive sleep apnea (OSA) is a growing public health hazard fueled by the obesity epidemic and an aging population. Untreated sleep apnea can result in significant consequences both in the short-term and long-term. We need to educate the public to recognize the symptoms of sleep apnea and to publicize that effective treatments are available. Positive airway pressure therapy remains the gold standard currently in treating OSA. Alternative treatments include an oral appliance or surgical options. This paper discusses the pharmacologic treatment of sleep apnea: goals include medications to address the ventilatory control of breathing, treat co-morbid diseases, treat associated health problems/complaints, address special issues, such as anesthetic precautions, and propose future targets.
Keywords: Obstructive sleep apnea, treatment, pharmacotherapy, targets, CPAP, Obstructive, apnea, anesthetic, hypertension, retropharyngeal, Bariatric surgery, cholinergic, nasal congestion, acromegaly, theophylline, aminophylline, caffeine, methylxanthine, Naloxone, oxyhemoglobin
Current Pharmaceutical Design
Title: Pharmacological Treatment of Obstructive Sleep Apnea
Volume: 17 Issue: 15
Author(s): Vivien C. Abad and Christian Guilleminault
Affiliation:
Keywords: Obstructive sleep apnea, treatment, pharmacotherapy, targets, CPAP, Obstructive, apnea, anesthetic, hypertension, retropharyngeal, Bariatric surgery, cholinergic, nasal congestion, acromegaly, theophylline, aminophylline, caffeine, methylxanthine, Naloxone, oxyhemoglobin
Abstract: Obstructive sleep apnea (OSA) is a growing public health hazard fueled by the obesity epidemic and an aging population. Untreated sleep apnea can result in significant consequences both in the short-term and long-term. We need to educate the public to recognize the symptoms of sleep apnea and to publicize that effective treatments are available. Positive airway pressure therapy remains the gold standard currently in treating OSA. Alternative treatments include an oral appliance or surgical options. This paper discusses the pharmacologic treatment of sleep apnea: goals include medications to address the ventilatory control of breathing, treat co-morbid diseases, treat associated health problems/complaints, address special issues, such as anesthetic precautions, and propose future targets.
Export Options
About this article
Cite this article as:
C. Abad Vivien and Guilleminault Christian, Pharmacological Treatment of Obstructive Sleep Apnea, Current Pharmaceutical Design 2011; 17 (15) . https://dx.doi.org/10.2174/138161211796197106
DOI https://dx.doi.org/10.2174/138161211796197106 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mechanisms Involved in the Genesis of Diabetic Nephropathy
Current Diabetes Reviews Heterocyclic Chalcone Analogues as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Polyphenol Supplementation as a Complementary Medicinal Approach to Treating Inflammatory Bowel Disease
Current Medicinal Chemistry The Contribution of Mannose Binding Lectin to Reperfusion Injury after Ischemic Stroke
Current Neurovascular Research Relationship Between the Pharmacokinetics of Levosimendan and Its Effects on Cardiovascular System
Current Drug Metabolism Conjugation of Resveratrol with RGD and KGD Derivatives
Protein & Peptide Letters Pharmacological Regulation of Dyslipoproteinaemia in Insulin Resistant States
Current Vascular Pharmacology Myocardial Inflammation in Autoimmune Diseases: Investigation by Cardiovascular Magnetic Resonance and Endomyocardial Biopsy
Inflammation & Allergy - Drug Targets (Discontinued) Molecule of the Month
Current Topics in Medicinal Chemistry Erythropoietin and Oxidative Stress
Current Neurovascular Research Insulin Secretion and Interleukin-1β Dependent Mechanisms in Human Diabetes Remission After Metabolic Surgery
Current Medicinal Chemistry Novel Anti-Arrhythmic Drugs for Atrial Fibrillation Management
Current Vascular Pharmacology Beclin 1 Biology and its Role in Heart Disease
Current Cardiology Reviews The Anti Inflammatory Effects of High Density Lipoproteins
Current Medicinal Chemistry The Vernakalant Story: How Did It Come to Approval in Europe and What is the Delay in the U.S.A?
Current Cardiology Reviews Malignancy and Radiation-Induced Cardiotoxicity
Cardiovascular & Hematological Disorders-Drug Targets Intervention for Cardiac Repair: A Clinical Perspective
Current Stem Cell Research & Therapy New Strategies and Biological Agents in the Treatment of Autoimmune Inflammatory Diseases. Progress and Challenges
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Chronic Migraineurs Form Carboxyhemefibrinogen and Iron-Bound Fibrinogen
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: Cardiovascular Drug Therapy in Paediatric Age: From Metabolomics to Clinical Practice)
Current Medicinal Chemistry